Covidien To Present At Leerink Swann Conference

Covidien (NYSE: COV), a leading global provider of healthcare products, will present at the Leerink Swann 2013 Global Healthcare Conference in New York, New York, on February 14, 2013. James C. Clemmer, President, Medical Supplies, will discuss the Company in a presentation scheduled to begin at 8:00AM ET.

A live audio webcast of the presentation can be accessed at Covidien’s Investor Relations website: http://investor.covidien.com.

About Covidien

Covidien is a leading global healthcare products company that creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence. Covidien manufactures, distributes and services a diverse range of industry-leading product lines in three segments: Medical Devices, Pharmaceuticals and Medical Supplies. With 2012 revenue of $11.9 billion, Covidien has 43,000 employees worldwide in 70 countries, and its products are sold in over 140 countries. Please visit www.covidien.com to learn more about our business.

Copyright Business Wire 2010

If you liked this article you might like

Jim Cramer -- Deal Activity in Specialty Pharma Reaches a Frenzied Pace

Mallinckrodt Buys Ikaria in $2.3 Billion Hospital Treatment Deal

Stryker and Smith & Nephew Are the Stars to Watch in Medtech's 2015 Merger Dance

Medtronic Avoids U.S. Taxes While Saddling Shareholders With a Hefty Tax Bill

Trim Positions in Stryker Ahead of Fourth-Quarter Earnings; Buy on Pullback